急诊科即时检测高敏肌钙蛋白的有效性:一项随机对照试验
WESTCOR即时检测研究为单中心前瞻性随机对照试验,将疑似急性冠脉综合征患者按1:1随机分配至0/1小时即时检测hs-cTnI组或0/1小时中心实验室hs-cTnT组。最终分析纳入1494例,即时检测组728例、对照组766例。急诊停留时间中位数两组分别为174分钟(95%CI 167至181)和180分钟(95%CI 175至189),中位缩短6分钟(95%CI -4至17)。即时检测组与对照组急性心肌梗死、死亡或急性血运重建发生率分别为83/728(11.4%)和72/766(9.4%)。结论认为即时检测hs-cTnI联合0/1小时诊断流程未带来有临床意义的急诊停留时间缩短,30天随访内心肌梗死、急性冠脉血运重建或死亡发生率无差异。
要点
- 疑似急性冠脉综合征患者随机接受0/1小时即时检测hs-cTnI或中心实验室hs-cTnT,急诊停留时间中位数174分钟 vs 180分钟,中位缩短6分钟(95%CI -4至17)。
- 预先设定的最小临床意义差值为15分钟,实际缩短6分钟(95%CI -4至17)未达到该阈值。
- 即时检测组急性心肌梗死、死亡或急性血运重建83/728(11.4%),对照组72/766(9.4%)。
- 30天随访期间两组心肌梗死、急性冠脉血运重建或死亡发生率无差异。
适用人群与场景
- 因疑似急性冠脉综合征症状就诊于急诊科的患者。
处置流程与药物剂量
- 干预组采用0/1小时即时检测hs-cTnI方案,对照组采用0/1小时中心实验室hs-cTnT检测方案。
研究设计与关键结果
- WESTCOR即时检测研究为单中心前瞻性随机对照试验,按1:1随机分配至0/1小时即时检测hs-cTnI组(干预)或0/1小时中心实验室hs-cTnT组(对照),主要终点为急诊停留时间。
- 最终分析纳入1494例,即时检测组728例、对照组766例;中位年龄61(四分位距22)岁,女性635例(42.5%)。
- 急诊停留时间中位数即时检测组174分钟(95%CI 167至181),对照组180分钟(95%CI 175至189),中位缩短6分钟(95%CI -4至17)。
- 急性心肌梗死、死亡或急性血运重建发生率即时检测组83/728(11.4%),对照组72/766(9.4%)。
- 30天随访期间两组心肌梗死、急性冠脉血运重建或死亡发生率无差异。
证据类型、等级与局限
- 证据类型:单中心前瞻性随机对照试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在急诊科实施即时检测hs-cTnI联合0/1小时诊断流程并未导致有临床意义的急诊停留时间缩短;30天随访内心肌梗死、急性冠脉血运重建或死亡发生率无差异。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
STUDY OBJECTIVE: To compare the effectiveness of high-sensitivity cardiac troponin (hs-cTn) point-of-care testing to central laboratory hs-cTn measurements when investigating patients presenting to the emergency department (ED) with symptoms of acute coronary syndrome.
METHODS: The WESTCOR point-of-care study was a single-center prospective randomized controlled trial where we randomized patients presenting with possible acute coronary syndrome in a 1:1 fashion to receive either 0/1-hour centralized hs-cTnT measurements (control) or 0/1-hour point-of-care hs-cTnI testing (intervention). We defined length of stay (LOS) in the ED as the primary endpoint and the minimum clinically meaningful difference as 15 minutes.
RESULTS: We included 1,494 patients in the final analysis, 728 in the point-of-care group, and 766 in the control group. The median (interquartile range) age was 61 (22) years, and 635 (42.5%) were women. Median LOS in the ED was 174 (95% confidence interval [CI] 167 to 181) and 180 (95% CI 175 to 189) minutes in the point-of-care and control group, respectively, resulting in a reduction in median LOS of 6 minutes (95% CI -4 to 17). Acute myocardial infarction, death, or acute revascularization occurred in 83/728 (11.4%) of point-of-care and 72/766 (9.4%) of control patients.
CONCLUSIONS: We found that implementing point-of-care hs-cTnI testing in the ED with a 0/1-hour diagnostic algorithm did not lead to a clinically meaningful reduction in ED LOS. We observed no difference in the incidence of myocardial infarction, acute coronary revascularization, or death during 30 days follow-up.
参考来源
- Thulin VIL, Jordalen SMF, Myrmel GMS, et al. Effectiveness of Point-of-Care High-Sensitivity Troponin Testing in the Emergency Department: A Randomized Controlled Trial. Ann Emerg Med. 2025. PMID: 40202469. doi:10.1016/j.annemergmed.2025.03.005
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。